Feb. 29, 2024

The American College of Radiology® (ACR®) Committee on Drugs and Contrast Media this week released a revised contrast statement that provides flexibility to facilities for contrast studies while maintaining patient safety.

If a physician provides direct supervision for the study — on-site or remotely — the revised statement makes clear a medical professional trained to manage contrast reactions should be on-site.

Healthcare providers with the capabilities specified in the contrast statement can provide the service on-site, as long as those qualifications and the process are consistent with state and local laws and policies, as well as the process and policies of the service site.


Related ACR News

  • ACR Presents to FDA on Oversight Considerations for GenAI Medical Devices

    The ACR® presented at the U.S. FDA Digital Health Advisory Committee meeting “Total Product Lifecycle Considerations for Generative AI-Enabled Devices.” Bernardo Bizzo, MD, PhD, ACR Data Science Institute® Associate Chief Science Officer, represented the College at the meeting.

    Read more
  • ACR DSI Releases 2 New Non-Interpretive Reading Room Use Cases

    use cases, artificial intelligence, reading room

    Read more
  • Direct Supervision for Contrast Studies

    We recommend that sites follow the ACR CT and MR Accreditation requirements for onsite supervision of contrast administration and management.

    Read more